The latest scandal is set to lead to a major restructure of the HSE.
A leading CervicalCheck campaigner says she's hopeful women do not have cancer after the latest testing controversy.
The HSE is reassuring 52 women who weren't given their repeat test results, and proved positive for the HPV virus, that the clinical risk to their health is low.
Of the 52 women involved, 26 have been referred for colposcopies.
In total, over 800 women had delayed results of their re-tests due to the technical problem at the Quest Lab in the US.
Cervical cancer survivor and patient advocate Lorraine Walsh says the issue could have had serious medical consequences.
''There isn't hopefully a potential woman coming out of this that could be diagnosed with cervical cancer'', she said.
''We really hope that doesn't happen, but it sounds like from clinical direction there that, that won't be the case.
''But it's the point of the communication error and a complete communication breakdown here, that could've been a lot worse clinically.''
Restructure.
In response to the latest scandal, Cabinet ministers are set to approve a major restructuring of the HSE.
It would establish six regional healthcare centres instead of the current centralised system.
It would be the most significant shake-up of the HSE's structures since it was founded in 2005 - and represent a return to a similar system to the one the executive replaced.
